ENGNW

Conviction 0HealthcareScan · Mon, Aug 10, 2026

ENGNW$0.0000-100.00%

ResistanceSupportVol 14

Vol MA14 3.9K

May 8May 27Jun 15Jul 2Jul 22Aug 7

enGene Therapeutics Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.engene.com ↗

Price0.0000

Change-100.00%

Gap-100.00%

Rel volume0.00×

Avg volume2.89K

Avg $ vol922.58

SMA 200.2332

SMA 500.1769

SMA 2001.53

Price vs 50-100.00%

Price vs 200-100.00%

MA stackbearish

50/200 cross—

Supertrendup · -0.0094

RSI (14)45

MACD hist-0.01

MACD crossbear · 0d

Stoch %K / %D0 / 33

ADX (14)10

+DI / −DI41 / 46

RSI divergence—

MACD divergence—

ATR %—

ADR %16.45%

52w high4.20

52w low0.0000

From 52w high-100.00%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width273.83%

%B0.13

Donchian pos0.00%

Donchian high0.5051

Donchian low0.0000

AVWAP (52w high)1.53

vs AVWAP high-100.00%

AVWAP (52w low)1.76

vs AVWAP low-100.00%

OBV trendDown

Chaikin MF (20)-0.02

Today vs 20d0.00×

Avg vol (14d)3.9K

Avg vol (20d)2.89K

Avg $ vol (20d)922.58

Market cap0

RS 3m (vs SPY)-105.70%

RS 6m (vs SPY)-114.11%

RS line new highNo

Trend template0/8

Technical rank—

1 week-100.00%

1 month—

3 months-100.00%

6 months-100.00%

1 year-100.00%

YTD—

P/E0.00

P/B0.00

P/S—

P/FCF0.00

EPS2.29

Div yield—

ROE-45.97%

ROA-38.14%

Debt/Eq—

Current12.57

EV/EBITDA0.24

Gross margin—

Net margin—

Rev growth—

EPS growth-112.73%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-29.83M

Revenue—

Net income-30.23M

Gross profit—

Free cash flow-100.72M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out—

Employees82

ListedWed, Nov 1, 2023

Free float—

Float %—

Short interest77.04K

Days to cover102.2d

Short volume—

Squeeze score62 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank—

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.4325

Support0.0000

Days since event—

Candle confirm—

News sentiment—

Financials as of Thu, Apr 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ENGNW

All disclosures →

No recent disclosed trades by Congress in ENGNW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ENGNW

No recent insider (Form 4) filings in ENGNW. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in ENGNW

EDGAR →

No recent SEC filings on file for ENGNW.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.